Pediatric Neurology Device Market Size, Share & Trends Analysis Report By Product (Neurosurgery Devices, Neurostimulator, Cerebrospinal Fluid (CSF) Management Devices, Other), By Service and Treatment (Electroencephalogram, Intrathecal Baclofen Therapy, Neurological Evaluations, Vagal Nerve Stimulation), By Neurological Subspecialty (Neuro-Oncology, Neuromuscular, Neonatal Neurology, Neuro-Immunology, Stroke), By Age Group (Neonates, Infants, Children, Adolescents), By End-User (Hospital, Healthcare Center, Specialty Clinics, Neurological Research Centres), By Application (Brain Tumour, Epilepsy, Autism Spectrum Disorder, Parkinson’s Disease, Others) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032

Market Overview

The global pediatric neurology device market size was valued at USD 2.72 billion in 2023. It is estimated to reach USD 5.67 billion by 2032, growing at a CAGR of 6.90% during the forecast period (2024–2032).

Pediatric neurology is a medical specialty that diagnoses and treats neurological disorders in neonates (newborns), infants, children, and adolescents. Child neurology encompasses diseases and disorders affecting the spinal cord, brain, peripheral nervous system (PNS), autonomic nervous system (ANS), musculature, and blood vessels in children and adolescents. A child neurologist or pediatric neurologist is a physician who treats minors with nervous system disorders.

Nervous system issues may arise from the brain, spine, nerves, or muscles. These factors can give rise to complications such as seizures, headaches, and impairments in developmental progress. A pediatric neurology device is a medical apparatus employed to diagnose and treat diverse neurological disorders, specifically in pediatric patients. These devices are commonly recommended by neurologists specializing in treating infants and individuals with nervous system disorders.

Market Dynamics

Global pediatric neurology device market drivers

Increasing prevalence of neurological disorders

Neurological disorders (NDs) are conditions that affect the body's autonomic, peripheral, and central nervous systems. Migraines, non-migraine headaches, multiple sclerosis, Alzheimer's disease and other dementias, Parkinson's disease, epilepsy, and other neurological disorders are non-communicable neurological disorders. According to a new United Nations report, up to one billion people, or approximately one-sixth of the world's population, suffer from neurological disorders such as Alzheimer's and Parkinson's disease, strokes, multiple sclerosis, and epilepsy, as well as migraines, brain injuries, and neuro infections, with approximately 6.8 million dying annually. According to statistics from around the world, 24 million people have Alzheimer's disease and other dementias, 62 million people suffer from cerebrovascular disease, 326 million suffer from migraines, and 50 million have epilepsy. Such factors drive the global market.

Rising awareness and early intervention

Neurological disorders are a group of conditions that impair the brain, spinal cord, and nerve functions. They can vary from moderate to severe and substantially impact an individual's quality of life. There is a growing awareness of neurological disorders currently. First, early diagnosis and treatment can enhance an individual's prognosis and delay the condition's progression. Secondly, increased awareness can result in increased funding for research and improved access to resources and support for those with neurological disorders. Such factors drive market growth.

Global pediatric neurology device market restraint

High treatment cost

The significant financial burden of treatment expenses hinders the pediatric neurology market. The expenses associated with consultations and treatments are high due to the limited availability of qualified professionals specializing in pediatric neurology. Children with neurological disorders often require multiple therapies, resulting in increased healthcare expenses.

Global pediatric neurology device market opportunities

Improved diagnostic technologies

The development of safe and efficient treatments for pediatric neurological illnesses leads to enhanced effectiveness in patient treatment. The advancement of diagnostic technologies and instruments must be ongoing. Conducting research and building sophisticated procedures to offer superior and helpful solutions is crucial. The first hand-held vagus nerve stimulator for episodic cluster headaches, an FDA-approved genetic health risks test, a neurosurgery tracking system, a TMS therapy system to treat depression, and a rehabilitation assistance robot for stroke and other neurological conditions patients are some of the new technologies in neurology.

Regional Analysis

Based on region, the global pediatric neurology device market is bifurcated into North America, Europe, Asia-Pacific, and LAMEA.

North america dominates the global market

North America is the most significant global pediatric neurology device market shareholder and is predicted to grow significantly during the forecast period. The United States is predicted to account for a sizeable portion due to factors like the rising prevalence of neurological disorders and the country's aging population. The major reason fueling the market's expansion is the rising prevalence of neurological disorders like epilepsy, Parkinson's disease, Alzheimer's disease, and neuromuscular disorders. According to the Pan American Health Organization, neurological diseases are to blame for 533,172 deaths in the region in 2019, of which 213,129 (40%) were caused by men and 320,043 (60%) by women. Similarly, age-standardized mortality rates were 32.9 per 100,000 people, with 33.1 deaths per 100,000 for males and 32.2 for women.

Asia-Pacific is predicted to expand significantly during the forecast period. This is due to the presence of high-population nations like China and India, which raises the likelihood that more people will develop genetic conditions and the growing number of strategies and trends adopted by market players. The Asia-Pacific region contains nations with enormous populations, such as China, Japan, Australia, and New Zealand, where the aging of the population will cause growth rates to accelerate in the coming years. It will increase demand for cutting-edge medical device technology utilized in diagnosing and treating numerous neurodegenerative conditions, such as Parkinson's disease and Alzheimer's disease. In addition, the past forty years of neuroepidemiology's growth and development in India have been demonstrated, with key historical moments highlighted. According to prevalence rates ranging from 967 to 4,070 per 100,000 people for the country's various regions, it is estimated that over 30 million people (excluding those with neuro-infections and severe traumas) have neurological illnesses.

Additionally, population-based studies have shown significant regional variation in the prevalence and incidence rates of common illnesses such as epilepsy, stroke, Parkinson's disease, and tremors. It is essential to use a standardized screening questionnaire and a consistent method for case identification and diagnosis to provide accurate national data on neurological illnesses. There is an urgent need for strategies to establish outreach neurology services to serve remote and rural areas, develop a national epilepsy control program, and establish stroke units at various levels of the healthcare pyramid. The higher prevalence of neurological disorders in rural areas, the 6–8 million people with epilepsy, and the high case fatality rates of stroke (27–42%) all call for such measures.

Europe will provide lucrative growth prospects for the pediatric neurology device market over the forecast period. In the majority of European nations, neurologists are the medical professionals who treat patients with neurological illnesses since they are so prevalent. More than 60% of people in Europe have a neurological disease, according to epidemiological data, which shows that prevalence closely correlates to patient numbers. Among all illness groups in Europe, neurological diseases have the third highest mortality and disease burden. In Europe, only about 85,000 neurologists are available, a small number compared to other macro-regions of the world and insufficient to meet the region's population of 900 million.

Segmental Analysis

The global pediatric neurology device market is bifurcated into products, services and treatment, neurological subspecialty, age group, application, and end-user.

By product

The neurostimulator segment is the leading category in the pediatric neurology device market, surpassing neurosurgery devices, cerebrospinal fluid (CSF) management devices, and others. Neurostimulators, such as deep brain stimulators and transcranial magnetic stimulation (TMS) devices, are in high demand for their effectiveness in treating conditions like epilepsy and cerebral palsy, and for their increasing use in managing chronic neurological disorders. These devices provide non-invasive or minimally invasive solutions that can significantly enhance patient outcomes, making them the preferred choice in the market. While neurosurgery devices and CSF management devices are also important, they cater to more specific needs and are generally utilized less frequently compared to the versatile and widely applicable neurostimulators.

Based on service and treatment, the global pediatric neurology device market is divided into electroencephalogram, intrathecal baclofen therapy, neurological evaluations, and vagal nerve stimulation.

The electroencephalogram segment owns the largest market share and is anticipated to expand significantly over the forecast period. A medical examination that measures the electrical activity of the brain is called an electroencephalogram (EEG). The scalp receives a lot of electrode applications. Numerous illnesses, such as epilepsy, sleep disorders, and brain tumors, can be diagnosed with EEG. An electroencephalogram (EEG) test uses tiny metal discs (electrodes) connected to the scalp to assess the brain's electrical activity.

Electrical impulses are the primary communication among brain cells, which are always active—even asleep. An EEG test looks for irregular electrical activity or waves in your brain. During the process, the scalp will be covered in electrodes, which are tiny metal discs with flimsy wires. The brain's activity generates minute electrical charges detected by the electrodes. A computer screen graph or a recording that can be printed out on paper shows the amplified charges.

Based on the neurological subspecialty, the global pediatric neurology device market is divided into neuro-oncology, neuromuscular, neonatal neurology, neuro-immunology, and stroke.

The neuro-oncology segment dominates the global market and is expected to grow significantly over the forecast period. The study of brain and spinal cord tumors is known as neuro-oncology. Imaging investigations are used in neurooncology diagnosis to identify the tumor's position, size, and extent. Magnetic resonance imaging (MRI) and computed tomography (CT) are the most popular methods. In addition to these techniques, positron emission tomography (PET), myelography, and angiography can also be utilized. The performance of cerebrospinal fluid analysis and lumbar puncture procedures may be deemed necessary.

In addition, neuro-oncology deals with tumors of the brain, spine, and nervous system, as well as the neurological side effects of cancer. Neurologists must stay current with these new advancements due to the emergence of novel treatments during cancer therapy. It applies particularly to neuro-oncology. Improvements in diagnosis and treatment, molecular neuro-oncology, new biological agents, and increasing rates of combination radiation and chemotherapy have led to small but significant gains in survival for tumors like gliomas.

The neuromuscular system refers to the network of muscles and nerves that cooperate to provide movement. Although numbness and discomfort can sometimes be signs of neuromuscular diseases, weakness is the most typical. Children's most prevalent neuromuscular diseases include muscular dystrophies, congenital myopathies, inherited neuropathies, and spinal muscular atrophy. Multiple progressive muscle illnesses known as muscular dystrophy weaken the muscular system and make it difficult to move, including walking.

Based on age group, the global pediatric neurology device market is divided into neonates, infants, children, and adolescents.

The children segment owns the largest market share and is predicted to grow at a significant rate during the forecast period. Inappropriate brain or spinal cord growth can result in neurological diseases that damage the brain itself, the brain's veins, or the spinal cord. Brain abnormalities are especially likely to affect premature babies. In addition, metabolic diseases like phenylketonuria, which can result in neurological issues, are often discovered at birth. Infants presenting with diverse types of neurological abnormalities will manifest various symptoms. Typical symptoms include aberrant mobility and developmental delays.

By application

The epilepsy segment holds the top position in the pediatric neurology device market, surpassing brain tumours, autism spectrum disorder, Parkinson's disease, and others. This dominance is attributed to the high occurrence of epilepsy in the pediatric population and the urgent requirement for effective diagnostic and therapeutic solutions. Essential devices for monitoring and managing epilepsy, such as EEG systems and neurostimulators, play a crucial role in controlling seizures and enhancing the quality of life for affected children. Although brain tumours and autism spectrum disorders are significant, the continuous demand for epilepsy management contributes to its largest market share in this segment. The emphasis on epilepsy reflects both its high prevalence and the technological advancements focused on addressing this challenging condition.

By end user

In the market for pediatric neurology devices, hospitals dominate the end-user segment compared to specialty clinics, neurological research centers, and other facilities. Their dominance is attributed to their abundant resources, extensive care capabilities, and a wide array of services, including advanced diagnostic and therapeutic procedures for pediatric neurology. Hospitals are capable of managing complex cases and providing essential multidisciplinary approaches for treating severe neurological conditions. Despite the crucial roles played by specialty clinics and neurological research centers, particularly in targeted care and research advancement, it is the scale and scope of hospitals that position them as the primary setting for the utilization of pediatric neurology devices. As a result, hospitals have the largest share of the market.

Recent Developments

• In July 2023, Anuncia Medical Inc., a Company specializing in advancing innovations for implantable and external cerebrospinal fluid (CSF) management systems and neurocritical care, announced the successful U.S. commercial launch of the ReFlow Mini Flusher device. It is FDA-cleared for use in patients living with hydrocephalus or similar conditions. Its reduced size and profile are designed to better support a broader hydrocephalus patient population, from infants to older adults.